Zevra Therapeutics (ZVRA) Research & Development (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Research & Development of $4.49 million for Q2 2026, up 30.7% from $3.43 million a year earlier and up 2.1% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Research & Development (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Zevra Therapeutics was $14.93 million, down 42.6% year-over-year; for FY2025, it came in at $12.74 million, down 69.7% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Research & Development was $42.1 million in FY2024 (+5.8%), $39.81 million in FY2023 (+101.0%), $19.8 million in FY2022 (+94.9%) and $10.16 million in FY2021 (+14.9%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development increased in two of the last eight quarters, with an average decline of 31.3%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2023, with growth of 180.8%; the weakest was Q1 2025, with a decline of 73.5%.
- According to Business Quant data, Research & Development for the three prior quarters was $4.39 million (Q1 2026), $2.62 million (Q4 2025) and $3.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Zevra Therapeutics | 612.26 Mn | -200.44 Mn | 38.18 Mn | 4.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.49 Mn |
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 8.35 Mn |
| Sep 30, 2024 | 10.95 Mn |
| Jun 30, 2024 | 10.52 Mn |
| Mar 31, 2024 | 12.28 Mn |
| Dec 31, 2023 | 11.42 Mn |
| Sep 30, 2023 | 12.30 Mn |
| Jun 30, 2023 | 7.43 Mn |
| Mar 31, 2023 | 8.66 Mn |
| Dec 31, 2022 | 6.54 Mn |
| Sep 30, 2022 | 5.39 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 2.24 Mn |
API Access
Zevra Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();